is semaglutide a sglt2 inhibitor of latest ADA guidelines for the use of glucose-lowering drugs in Link To And Excerpts From

Certainly, hyperglycaemia (or oral glucose tolerance) did not turn out to be a strong predictor of GLP-1 secretion, suggesting that other characteristics of type 2 diabetic patients not represented by elevated glucose concentrations in the fasting or postprandial state may determine GLP-1 secretion, although opinions differ [54]

Safety, tolerability, access, cost, and individual response all play important roles

Barbati, S.A

doi: 10.1056/nejmc1602096

And as platforms bank on questionable drug and wellness advertising revenue , Maxwell says creators they used to work alongside have pivoted to sponsored GLP-1 posts

A: Alternatives to estradiol patches include FDA-approved transdermal gels and sprays, oral estradiol (with a different clot-risk profile), vaginal estrogen preparations for genitourinary symptoms, and compounded transdermal estradiol creams from PCAB-accredited pharmacies